Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - IOVANCE BIOTHERAPEUTICS, INC. | v403564_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - IOVANCE BIOTHERAPEUTICS, INC. | v403564_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - IOVANCE BIOTHERAPEUTICS, INC. | v403564_ex32-2.htm |
| EX-10.46 - EXHIBIT 10.46 - IOVANCE BIOTHERAPEUTICS, INC. | v403564_ex10-46.htm |
| EX-32.1 - EXHIBIT 32.1 - IOVANCE BIOTHERAPEUTICS, INC. | v403564_ex32-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - IOVANCE BIOTHERAPEUTICS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - IOVANCE BIOTHERAPEUTICS, INC. | v403564_10k.htm |
| EX-10.47 - EXHIBIT 10.47 - IOVANCE BIOTHERAPEUTICS, INC. | v403564_ex10-47.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statement No. 333-200418 on Form S-3 of Lion Biotechnologies, Inc. of our reports dated March 16, 2015, relating to the financial statements and effectiveness of internal control over financial reporting, which appear in this Form 10-K.
/s/ Weinberg & Company, P.A.
Los Angeles, California
March 16, 2015